BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32067049)

  • 1. Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017.
    Doyle JD; Beacham L; Martin ET; Talbot HK; Monto A; Gaglani M; Middleton DB; Silveira FP; Zimmerman RK; Alyanak E; Smith ER; Flannery BL; Rolfes M; Ferdinands JM
    Clin Infect Dis; 2021 Mar; 72(6):995-1003. PubMed ID: 32067049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.
    DiazGranados CA; Robertson CA; Talbot HK; Landolfi V; Dunning AJ; Greenberg DP
    Vaccine; 2015 Sep; 33(38):4988-93. PubMed ID: 26212007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Clin Infect Dis; 2016 May; 62(9):1092-1099. PubMed ID: 26908801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
    Balasubramani GK; Choi WS; Nowalk MP; Zimmerman RK; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Jackson ML; Jackson LA; Chung JR; Spencer S; Fry AM; Patel M; Flannery B;
    Vaccine; 2020 Sep; 38(42):6562-6569. PubMed ID: 32800465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Lee JKH; Lam GKL; Shin T; Samson SI; Greenberg DP; Chit A
    Vaccine; 2021 Mar; 39 Suppl 1():A24-A35. PubMed ID: 33422382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Vaccine; 2015 Aug; 33(36):4565-71. PubMed ID: 26187260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
    Becker DL; Chit A; DiazGranados CA; Maschio M; Yau E; Drummond M
    Hum Vaccin Immunother; 2016 Dec; 12(12):3036-3042. PubMed ID: 27669017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.
    Chung JR; Flannery B; Thompson MG; Gaglani M; Jackson ML; Monto AS; Nowalk MP; Talbot HK; Treanor JJ; Belongia EA; Murthy K; Jackson LA; Petrie JG; Zimmerman RK; Griffin MR; McLean HQ; Fry AM
    Pediatrics; 2016 Feb; 137(2):e20153279. PubMed ID: 26738884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
    Comber L; O Murchu E; Jordan K; Hawkshaw S; Marshall L; O'Neill M; Teljeur C; Ryan M; Carnahan A; Pérez Martín JJ; Robertson AH; Johansen K; de Jonge J; Krause T; Nicolay N; Nohynek H; Pavlopoulou I; Pebody R; Penttinen P; Soler-Soneira M; Wichmann O; Harrington P
    Rev Med Virol; 2023 May; 33(3):e2330. PubMed ID: 35119149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans.
    Richardson DM; Medvedeva EL; Roberts CB; Linkin DR;
    Clin Infect Dis; 2015 Jul; 61(2):171-6. PubMed ID: 25829001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.
    Palmu AA; Pepin S; Syrjänen RK; Mari K; Mallett Moore T; Jokinen J; Nieminen H; Kilpi T; Samson SI; De Bruijn I
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13270. PubMed ID: 38569647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update.
    Lee JKH; Lam GKL; Yin JK; Loiacono MM; Samson SI
    Vaccine X; 2023 Aug; 14():100327. PubMed ID: 37333054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians.
    Cataldi JR; Hurley LP; Lindley MC; O'Leary ST; Gorman C; Brtnikova M; Beaty BL; Crane LA; Shay DK; Kempe A
    J Gen Intern Med; 2021 Jul; 36(7):2030-2038. PubMed ID: 33483822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
    Boikos C; Fischer L; O'Brien D; Vasey J; Sylvester GC; Mansi JA
    Clin Infect Dis; 2021 Sep; 73(5):816-823. PubMed ID: 33605977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Attenuated and Inactivated Influenza Vaccine Effectiveness.
    Chung JR; Flannery B; Ambrose CS; Bégué RE; Caspard H; DeMarcus L; Fowlkes AL; Kersellius G; Steffens A; Fry AM; ; ;
    Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30617239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the 2010 and 2011 Southern Hemisphere trivalent inactivated influenza vaccines against hospitalization with influenza-associated acute respiratory infection among Thai adults aged ≥ 50 years.
    Dawood FS; Prapasiri P; Areerat P; Ruayajin A; Chittaganpitch M; Muangchana C; Baggett HC; Olsen SJ
    Influenza Other Respir Viruses; 2014 Jul; 8(4):463-8. PubMed ID: 24490684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
    McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
    JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine prevents medically attended influenza-associated acute respiratory illness in adults aged ≥50 years.
    Chen Q; Griffin MR; Nian H; Zhu Y; Williams JV; Edwards KM; Talbot HK
    J Infect Dis; 2015 Apr; 211(7):1045-50. PubMed ID: 25336724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
    King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
    Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.